Cancer is a complex, multifaceted disease. Cellular systems are perturbed both during the onset and development of cancer, and the behavioural change of tumour cells usually involves a broad range of dynamic variations. To an extent, the difficulty of monitoring the systemic change has been alleviated by recent developments in the high-throughput technologies. At both the genomic as well as proteomic levels, the technological advances in microarray and mass spectrometry, in conjunction with computational simulations and the construction of human interactome maps have facilitated the progress of identifying disease-associated genes. On a systems level, computational approaches developed for network analysis are becoming especially useful for providing insights into the mechanism behind tumour development and metastasis. This review emphasizes network approaches that have been developed to study cancer and provides an overview of our current knowledge of protein^protein interaction networks, and how their systemic perturbation can be analysed by two popular network simulation methods: Boolean network and ordinary differential equations.
INTRODUCTION
Advances in high-throughput sequencing and microarray technologies have significantly increased the pace of detecting mutations in genes and have allowed us to measure gene expression levels on a genome-wide scale. Consequently, the large amounts of data associated with these technological advances have promoted the idea of formulating cancer studies under the framework of network analysis and systems biology, through which the essential features of biological processes such as non-linearity and dynamics can be studied at the systems level [1] [2] [3] . Topology-wise, the conventional concept of a cancer network or system can be as simple as a signalling pathway that enables cells to turn on or switch off specific functions once they receive signals or stimulants from the surrounding environment ( Figure 1a) . A more complicated view of cancer networks considers feedback loops and crosstalk between signalling pathways (Figure 1b) . Cancer studies become even more complex when one considers all potential interactions at the gene or protein level, and networks can become complex webs in which the topology of clear linear signalling pathways dissolve (Figure 1c ). In addition to the reactions between genes or proteins inside a cell, interactions at the 'supra-level' (Figure 1d )-i.e. communications between cancer cells and their surrounding environments-must also be considered for a more complete understanding of the etiology of cancers [2, 4] . The cell-environment network enables us to gain insights into how cancer cells maintain their population while competing for resources with normal cells, and how we can effectively treat cancer patients with various kinds of therapeutic approaches.
In this review, we will present a general picture of how mathematical modelling has been applied in studying cancer networks, with an emphasis on their dynamics aspect. We start with a static view of network modelling and discuss the sources available for constructing these networks, and then focus on the application of two dynamic modelling approaches that have been commonly used to study the dynamics of cancer networks. The first modelling approach we will discuss is Boolean network (BN) algorithms, which have been applied to analyse pathway-and web-like networks. The second modelling approach discussed describes the use of ordinary differential equations (ODEs), often applied to interpret both intra-cellular pathways and cell-environment networks. These two models can be considered complimentary to each other in the sense that the former has a more qualitative nature while the latter is quantitative.
STATIC NETWORK ANALYSISçTHE HUMAN INTERACTOME
The space inside a cell is a very crowded environment full of biological macromolecules. It is through frequent interactions between the biological molecules, either permanently or transiently, that numerous functions of a cell can be sustained. For example, cell growth and differentiation are regulated by various signalling pathways that are conducted through protein-protein interactions (PPIs). Thus, PPI networks (interactome) allow us to understand how proteins are organized to perform functions within a cell, which provides further insights into cellular physiology. Therefore, the construction and analysis of an interactome, albeit static by nature, is a popular and qualitatively efficient method to study a cell's itinerary of protein components, and determine which of these components are likely to interact to control and maintain cellular systems both in diseased and non-diseased states.
Building networks
Up to date PPI networks for cancer studies are generally constructed from pair-wise PPIs recorded in various databases. Most of the primary databases collect potential PPIs from the scientific literature, which have been experimentally verified; some of these popular databases are IntAct [5] , MINT [6] , DIP [7] , HPRD [8] , BioGRID [9] , BIND [10] and MIPS/MPACT [11] . Statistics for the number of PPIs within each of these databases change constantly- Table 1 provides the latest statistics available at the time of writing this review. Therefore, the website for each database should be consulted to keep track of current statistics (URLs provided in Table 1 ); for a detailed overview of the extent and rate of PPI accumulation, see the works of Mathivanan et al. [12] and Lehne and Schlitt [13] . Besides these primary databases, there are others, for example STRING [14] , that not only store experimentally verified interactions (either novel measurements or an integration of previously reported interactions from various databases) but also store predicted interactions which have been annotated by computational methods such as gene neighbourhoods, gene fusions, co-occurrence of genes and gene co-expression (see Shoemaker and Pancheko [15] for details of these methods). STRING also uses text-mining techniques. Hence, the likelihood of each PPI recorded being a true-positive in each of these databases varies according to the methodologies by which they have been determined. Two widely used experimental techniques to screen for PPIs in humans are Yeast two-hybrid (Y2H) [16] and Tandem Affinity Purification-Mass Spectrometry (TAP-MS) [17] , which have previously been shown to effectively validate PPIs in yeast [16, 18, 19] and have been successfully applied to generate PPI data for the human interactomes [20] [21] [22] . An important issue to keep in mind is that experimental methods such as Y2H have a higher false-positive rates [23] , and even methods, which determine all the proteins contributing to a multimeric complex, such as TAP-MS, are prone to assigning false-positive interactions because not all the component protein pairs will necessarily be making direct contact with each other [24] .
In additional to PPIs measured by the experiments mentioned earlier, several PPI networks in the literature are actually built from probabilistic models considering other higher order information such as protein domain data and genome-wide gene expression data (see review by Ideker and Sharan, 2008 [25] ). The probabilistic PPI networks can be considered as higher confidence networks because the noise from raw interaction measurements is reduced. Furthermore, alternative PPI sub-graphs can also be derived from experimental PPI data-for example, structural properties of a large PPI network can be studied through its random sub-graphs [26] .
As a means to establish a uniform standard for recording PPIs, The International Molecular Exchange consortium (IMEx) has been established [27] . IMEx aims to develop a minimum standard for the curating and exchanging of data, to avoid duplications of annotation effort between the databases and to make all interaction data available in a single search interface. As a part of this effort to establish a standard for data curation, the proteomics standards initiativemolecular interaction (PSI-MI) [28] has also been developed. PSI-MI aims to provide a controlled vocabulary for representation of interacting proteins and method of PPI detection. It records PPI data in tab-delimited text files as well as XML file formats, and has been adopted by many databases such as IntAct, MINT, DIP and BioGRID.
Therefore, following the PSI-MI guidelines to not duplicate entries between databases, no one database provides a completely exhaustive dataset of PPIs. Besides, to increase confidence in the PPIs observed, there is a need to integrate data from the various databases and many studies combine PPIs from various databases rather than relying on the information of one database. It is generally straightforward to integrate PPIs from different databases because all the earlier-mentioned databases can be downloaded as a flat file and then integrated into a larger network. With regards to data integration of PPIs from various databases, there are several meta-databases, such as APID [29] , PINA [30, 31] and UniHI [32] that provide more comprehensive PPIs for efficient network studies. However, many of these meta-databases do not update at the same rate as the primary databases or may only concentrate on interaction data for one species. Except for PINA, due to complex licensing issues, none of these databases provide an option to download their complete database. However, new initiatives are continually being developed to aid the experimentalist and to give them confidence in the interesting interactions they may uncover. For example, the IntAct database has recently set up a tool called PSICQUIC [33] , which serves as a centralized platform that allows the user to view interactions for a given protein collected from a variety of different databases.
PPI networks and cancer
Versions of the human interactome have been constructed to study a variety of diseases, and to predict new disease genes or to further study genes already known to be associated with disease [34] [35] [36] . Cancer studies in particular have benefited from such approaches [37] . Prediction methods usually integrate multiple genomic data sources to identify novel cancer genes. For example, gene expression data can be mapped to PPI networks to gain an additional layer of topological information that can be used to predict novel cancer genes [38] . Moreover, the careful construction of cancerperturbed PPI networks, such as those involved in apoptosis [39] , are finding utility for the identification of potential cancer drug targets.
Biomarker discovery for the classification of cancer disease and prognosis has traditionally been based on microarray gene expression data. The use of PPI networks to derive an additional set of features, based on topology, can produce more effective classifiers [40] . Using a similar approach, Chuang et al. [41] find that the sub-network markers are more reproducible than individual marker genes selected without topological information and such markers are able to achieve higher classification accuracy of metastatic versus non-metastatic breast cancer tumours.
On a broader scale, topological analysis of the human interactome to study the essentiality of cancer genes in general has been undertaken by several groups, and different opinions have been brought forward. For example, our own work [42] suggests that cancer genes are central to the human interaction network and have stronger connectivity than non-cancer genes. This view appears to be supported by a recent analysis [43] using a different approach, with different databases. However, these observations are not universally accepted, and the work of Goh et al. suggest that cancer genes are more likely to reside within the periphery of networks and are less connected than non-cancer genes [44] . As there are a number of sources of error in such analyses, this debate is likely to continue. For example, a bias may occur in the number of proteins found to interact with cancer proteins, because proteins associated with cancer, due to their perceived medical importance, may have been more purposely studied [45] . The fact, that the interactome is far from complete [46, 47] could be another contributing factor.
DYNAMIC NETWORK ANALYSIS
The static PPI networks, as mentioned earlier, serve as useful tools for qualitative analysis of cancers such as identification of oncogenes and potential drug targets. On the other hand, further in-depth studies, such as the etiology of oncogenes and the functional mechanism of cancer drugs, benefit more from non-static network analysis. The directed graphs in non-static networks provide a framework for formulating functions that describes the flow of reactions, and hence the effect of oncogenes and cancer drugs can be estimated as perturbations, which affect the dynamics of these networks. Currently, the main type of non-static networks in biology are signalling pathways ( Figure 1a and b), the information for which can be found in databases such as BioCarta (http://cgap.nci.nih.gov/Pathways/BioCarta_Path ways), KEGG [48, 49] , Reactome [50] and Pathway Interaction Database from Nature [51] .
Directed networks enable one to link structural properties of networks to their dynamics through network motifs. It is natural to think of networks as a set of sub-networks; motifs are sub-networks which form the basic building blocks of complex networks [52] . Actually, the idea of motifs has been introduced as statistically significant patterns of local interactions between network elements [53] . Several motifs have been shown to be functionally relevant in biological networks [53] . For example, the feed-forward loop motif acts as an asymmetric delay circuit: It shows a delayed response on activation and a rapid response in the opposite direction on deactivation [54] . Such a characteristic can be advantageous for gene regulation in noisy environments with fluctuating signals. Besides dynamics, studies on network motifs have given insight into the evolutionary origins of complex networks, robustness [55] and function [56] . These network motifs have been extensively studied in the context of ODEs, as discussed further in the ODE section.
There are a number of computational methodologies to represent and simulate the dynamic of biological networks, such as stochastic process algebra (see review of [57] ), agent-based modelling (see reviews of [58, 59] ) and dynamic Bayesian networks [60] , which has the potential to include cell-cell interaction information along with key networks within each cell that regulate their interaction [61] . Nevertheless, although we must limit ourselves to describing just two methods due to space limitations, they are two modelling approaches extensively employed by both the computational network biology community and those interested in the dynamics of cancer.
Boolean networks
BN modelling of genetic regulatory networks was first introduced by Kauffman [62] . In his model, gene expression is quantized as two states, either 'on' or 'off' (see an example of a simple BN model in Figure 2) . By simplifying the regulatory networks into binominal states, BNs makes it feasible to simulate the behaviour of large regulator networks in a qualitative way.
In the BN framework, a global view of a network's dynamics can be analysed by its attractor landscape. Take genetic networks as an example (Figure 3) , the binominal state of the individual genes at a given time point is defined as gene activity pattern (GAP). Therefore, for a network of size n, we have 2 n possible GAPs. The state of GAPs can be further classified into two groups: 'unstable' and 'stable' states. It is the transition process between the unstable states of GAPs, so called 'the basin of attraction', that describes the attractor landscape. [64] . Dynamical trajectories of the 1764 protein states (nodes) flowing to the G1 check point (bottom node). Arrows between states indicate the direction of dynamic flow from one state to another. The cell-cycle sequence is represented with thick edges. The size of a node and the thickness of an arrow are proportional to the logarithm of the traffic flow passing through them. The transition process is ended by a stable state that is known as an attractor. A general assumption of BNs is that, once an attractor state is reached, the system remains in the stable state unless a perturbation or mutation is applied. There are two types of stable attractors, singlepoint attractors and cyclic attractors where the latter is essentially a stable cycle of several singlepoint attractors. Cyclic attractors tend to be a direct result of having feedback loops in the network. Although the simplified dynamics of a regulatory network depicted by BNs is different from the actual dynamical regulatory activity of biological cells, BN models have been successful in capturing the qualitative phenomena of biological networks [65] [66] [67] [68] . This suggests that the underlying global dynamics of most biological networks, including their steady-states, is mainly regulated by the structure of the networks rather than its quantitative parameters [69] . For example, cellular steady-states representing distinct phenotypes have been directly related to BN attractors [64, 70] . For a discussion regarding the appropriateness of BN modelling of biological systems-whether we have the 'right' type of data to infer BN models and what can be learnt from them-the reader is referred to a recent review of BN models of cellular regulation by Bornholdt [71] .
In this review, we focus our attention on how BN models have been used to probe and understand cancer-related pathways. We also look at the limitations of the classical BN framework and highlight recent approaches that extend BNs to a more quantitative framework.
BN modelling of cancer-related pathways
BN models are becoming an important tool for uncovering the dynamical rules governing biological networks because of their feasibility to simulate the dynamics of large networks. Unlike other qualitative approaches, such as ODE networks, BN is applicable when the value of dynamical parameters are not available-a common bottleneck for most of the methods that require the value of rate constants to simulate the dynamics of a network. This has made BN models a popular approach for studying cancerrelated pathways.
BN models are particularly useful for studying the short-and long-term effects of 'knock-outs' and 'knock-ins' on a biological network. A classical approach is to compare the end-states of nodes in the attractors of the wild-type network, to those of the perturbed network. For example, Zhang et al. [72] found novel mediators that enable the long-term survival of competent cytotoxic T-lymphocytes in large granular lymphocyte T-cell leukaemia by knocking out the function of individual nodes of a T-LGL survival signalling BN model.
A key hallmark of cancer is the accumulation of mutations and most importantly, the sequence in which these occur [73] . Recently, a BN model has been applied to infer the gene regulatory network that underlies healthy cells and to predict the sequence of gene mutations that occurred during the tumour progression process [74] . The proposed algorithm is then applied to pathways that involve the p53 gene.
Another powerful aspect of BN models is the ability to analyse and compare 'healthy' and 'cancerous' networks through their signalling logic. Such analysis is performed in the study of immediate-early signalling events in cancerous liver cells [75] : First, several BN models are developed by training a literature-based prior knowledge network against biochemical data obtained from primary human hepatocytes and four hepatocellular carcinoma cell lines exposed to combinations of cytokines and small-molecule kinase inhibitors. Then the BN models, each representing individual cell types mentioned earlier, are clustered into normal and diseased sets according to their topologies, reflecting the systematic differences in signalling logic.
As highlighted in the previous section, BN attractors can sometimes be directly related to cellular phenotypes. In [76] , a BN model of cell-fate decision in response to death receptor engagement is devised. The model provides a generic high-level view of the interplays between NFkB pro-survival pathway, RIP1-dependent necrosis, and the apoptosis pathway in response to death receptor-mediated signals. Figure 4 shows the BN attractor states realized by the model; the k-means clusters of these attractor states directly relate to the survival, apoptosis and necrosis phenotypes.
BN modelling has also been applied to characterize cell adhesion of normal and tumourigenic stem cells in the human colon, particularly in early tumourigenesis [77] . Instead of using nodes to represent physical entities such genes and proteins, there are BN models using nodes to represent conceptual entities such as whole pathways and phenotypes. In the work of Rodriguez et al. [78] , a BN model of the FA/BRCA is used to investigate alternative DNA repair pathways that become active whenever the FA/BRCA pathway is defective. The model consists of nodes representing ICL repair process mediated by the nodes representing FA/BRCA pathway, the activation of Checkpoint proteins observed by recurrent DNA damage, and the repair of DNA double-strand breaks and DNA adducts. The BN approximation also has its relevance in synthetic biology, for example, in a recent study by Xie etal. 
From qualitative to quantitative BNs
As highlighted earlier, BNs are strictly qualitative in nature and may not be able to capture all the features governing the dynamics of biological networks. This is partly due to the fact that realistic time-scales and continuous concentrations are not represented in BNs. Time in a BN is captured by its updating rule, and the most commonly used updating mechanism is synchronous updating where every interaction is updated in parallel at each time-step. This updating mechanism inherently assumes that all processes occur within the same time-scale and thus makes no distinction between rates of transcription, translation, association and other distinct cellular processes. Hence, alternative updating approaches have to be implemented if the timing of interactions within a biological network is different. Regarding this, several methods have been developed to address the time-scales issues of BNs. The most common approach is to classify interactions into groups that share similar time-scales and update their status asynchronously [80] . Faure et al. [81] provide models for both synchronous and asynchronous updating strategies and assess the differences in attractor landscapes when applied to a BN model of the mammalian cell-cycle. Moving towards more quantitative BNs, Albert et al. [82] embedded piece-wise linear models into the Boolean functions, which encompass node concentrations and decay rates, whereas Wittmann et al. [83] used multivariate polynomial interpolation to transform logic operations of BN functions into a system of ODE. Another approach is to integrate quantitative models and BNs together into a multiscale model such as the one developed by Ribba et al. for the modelling of tumour growth [84] . An alternative approach for quantitative BNs is the method devised by Jack et al. [85] , where an asynchronous BN is built to model early molecular signalling events that lead to proliferative changes in hepatocytes. An ensemble of such models then estimates the aggregate response across a cell population of hepatocytes. With sufficient data such a model can also simulate the response to different concentrations of extracellular ligands. More interestingly, non-monotone interactions can also be modelled by using multi-valued logic to replace the binominal 'on', 'off' behaviour [77, 80] . The multi-valued logic can associate different qualitative phenomena to different activation states (or thresholds) of a given regulator, thus qualitatively accounting for non-linear behaviour of a system. Fuzzy Logic FL has also been introduced as an attractive approach for modelling cell signalling networks [86] . The FL formalization is able to handle data in a non-discrete fashion and allows multiple rules to fire simultaneously to varying degrees. However, it is worth mentioning that introducing quantitative parameters into BNs may compromize the benefit of parameter-free BNs. Hence, it is important that such models are inclusive of any known quantitative parameters, but not limited to such information for their simulation.
Like many other models, most BN models of the pathways discussed earlier have been derived through a manual literature search of relevant interactions. Although BN models built on manually curated interactions are generally high in confidence, this limits the coverage of interactions to those that have been sufficiently studied in literature and there may also be a bias in the degree of the nodes in the network. For example, more interesting genes are more likely to have a high degree, given that such genes and their interactions are more intensively studied.
To increase coverage and reduce biases, the use of BN inference methods, such as the ones reviewed by Hickman et al. [87] , is suggested. However, these methods generally result in a large number of different yet equally plausible networks, all of which satisfy the restraints brought about by the expression data they are derived from. Though such networks can still be used if encompassed into a Probabilistic BN [63] in which the uncertainty of certain interactions is automatically accounted for, BN inference methods, just like any other dynamic network inference methods, are ultimately bottlenecked by the availability of time-course expression data.
Several software packages are available for the simulation of networks; most notably CellNetAnalyzer [88] , GinSim [89] , SQUAD [90] and Genetic Network Analyzer (GNA) [91] . Some of which include model repositories, intervention and analyses software, and the ability to move away from a purely qualitative framework. For example, SQUAD is able to handle non-linear differential equations; GNA enables continuous modelling whereas CellNetAnalyzer contains plugins that introduce ODEs into the network.
ORDINARY DIFFERENTIAL EQUATIONS
Construction of ODE networks is currently the mostly common mathematical approach to describe the dynamics of a biological pathway. In the context of an ODE network, a target pathway is usually described as a series of coupled chemical reactions of its component molecules, such as the association and disassociation between molecules, and the production and degradation of individual species. The rate of the reactions is then represented in terms of mass action kinetics, which is an empirical approximation states that the rates of a reaction are proportional to the concentration of the reactants. Derivations from the law of mass action, such as Michaelis-Menten kinetics and Hill equations, are also commonly applied to ODEs for describing macromolecule-macromolecule and macromolecule-ligand interactions, respectively.
One important aspect of the network analysis that ODE has been applied to is to understand how specific biological functions emerge from the embedded dynamic interactions. For this aspect, the 'bottomup' approach, i.e. breaking down a network into small modules, or 'network motifs', that serve as building blocks for implementing the network function, has been widely applied in network analysis [52, [92] [93] [94] [95] . Detailed studies of the dynamical features of various feedback motifs have revealed their role in regulating the behaviour of biological pathways. For example, in the context of cancer networks, positive feedbacks, negative feedbacks and negative feed forward loop motifs are known to behave as robust switch, adaptive and robust response, respectively; the reader is referred to the review of Cloutier and Wang [96] on how ODEs are applied in studying the dynamics of various feedback motifs.
More recently, combination of protein structure and ODEs models of pathway dynamics has been shown as a promising approach for analysing the systemic impact of point mutations in proteins. Kiel and Serrano [97] studied how point mutations in the Ras-binding domain of c-Raf (RafRBD) affect the expression of the downstream protein ERK by investigating the structure of RafRBD and constructing an ODE model describing the ERK signalling pathway. The work of Cheng et al. (submitted) further explores the practicality of this structural systems approach by formulating ODEs to describe two biological systems: (1) the G2 to M transition mechanism that controls the cell length in fission yeasts; (2) the human ERK signalling pathway. The study shows that the systemic impact of point mutations can be reasonably gauged through a systemic impact factor (SIF) that is a function of free energy change of host proteins (proteins that contain point mutations) and the sensitivity of host proteins in terms of regulating the expression profile of a downstream reporter protein (see Figure 5 for an overview of the methodology). Furthermore, this work indicates that a reduced ODE model that only describes the dynamics of the key proteins in a biological pathway may be used as an alternative when there are missing proteins in a target pathway or when some rate constants cannot be easily measured experimentally.
In addition to the study of cellular pathway dynamics, ODE networks have also been widely applied in studying the interactions between cancer cells and their surrounding environments (cell-environment network, Figure 1d) . For example, modelling tumour growth under limited nutrients [98] ; studying competition between tumour and environment (the mechanism of tumour invasion) [99] [100] [101] [102] [103] ; understanding the competition of nutrient for cancer growth [104] ; simulating cancer cell growth under oxygen tension [105] [106] [107] ; modelling the interactions between tumour growth and immune response [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] . Moreover, there are ODE models developed for studying interactions between tumour and non-tumour cells, such as the growth of tumour cells within normal tissues [122, 123] or tumour cells accompanied by proliferating and quiescent cells [124, 125] . Other types of ODE models related to the cell-environment network, include tumour growth under the effect of angiogenesis [ [126] [127] [128] ; modelling emergence of sub-populations of a tumour tissue [129] ; modelling necrosis based on a cell-water two-phase model [130] and modelling tumour cell proliferation at the stationary state considering cell-to-cell variability of cell cycle transit times [131] .
Another important and intensely researched topic related to ODEs is modelling how tumour cells respond to therapeutic treatments. The objective here is to identify the time and amount of treatment that should be delivered to tumour cells to achieve the optimal reduction or inhibition of tumour growth. For example, there are model studies of cancer growth under the influence of both chemotherapy and immunotherapy [132] [133] [134] ; immunotherapy alone [135] [136] [137] [138] [139] ; chemotherapy alone [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] ; anti-angiogenic therapy alone [152] [153] [154] [155] [156] [157] ; radiotherapy and anti-angiogenic therapy [158, 159] ; anti-angiogenic and chemotherapy [160] [161] [162] ; cytoreductive nephrectomy for patients with renal cell carcinoma [163] ; and non-specific therapeutic strategies [164] [165] [166] (see review by Swan [167] , for works before year 1990). Moreover, ODE models can also take into account the effect of drug resistance on heterogeneous tumours [168] [169] [170] [171] [172] , on tumours influenced by vasculature [173] and on multi-cell spheroids and monolayer cultures [174] . Other models can predict tumour response to therapy after oncogene inactivation [175] , model the effect of anti-tumour agent on the dynamics of the cell cycle [176] , the dynamics of tumours infected by a replication-competent virus [159] or even help in the discovery of new cancer drugs [177] .
Support for ODE-oriented network analysis
As with any other simulation approaches, ODE networks have their limitations or downsides. One specific issue, perhaps the most difficult one to tackle, is parameter inferences. This is due to the fact that there are usually limited time-course expression data available for reliably determining the value of rate constants in an ODE model describing network dynamics. Regarding this issue, a 'decomposition' approach is often employed to circumvent the problem, i.e. break a network into smaller modules that are responsible for maintaining the core function of a network. The approach is inspired by what we observe in nature: molecules in a cell often function as a small group to accomplish a relatively autonomous function such as protein synthesis and DNA replication [178] . Regarding this, Petri nets have been widely applied to modularize networks that are functional at the cellular [179] [180] [181] or multicellular [182, 183] level (see reviews by Matsuno, 2006 [184] and by Chaouiya, 2007 [185] for more information of the application of Petri nets in systems biology). Alternatively, other approaches such as applying Dynamic Bayesian Network to estimate the parameter space [186] or multi-objective optimizations [187, 188] , also support the parameter inference of ODE networks.
CONCLUSIONS AND FUTURE DIRECTIONS
Static PPI networks are informative, particularly at the beginning of a cancer study. Many features can be mapped to a carefully constructed human interactome, such as gene expression levels and location of non-synonymous single nucleotide polymorphisms (nsSNPs). From such mappings, it is possible to locate interesting regions of interactome space, regions that might be particularly enriched with cancer genes [189] . However, the systemic impacts of such cancer genes, especially the combinatorial effects of oncogenes, may be better studied by analysing their perturbations on the dynamics of non-static networks, such as signalling pathways and gene regulatory networks. Here, we have described two of the more common dynamic approaches used to analyse non-static networks and their sub-networks: BN and the implementation of ODEs. These methods have been regularly applied to study gene regulatory networks and signalling pathways. Both these methodologies have the potential to locate and understand bottlenecks and switches associated with cancer disease processes. However, as with all current algorithms, there are shortcomings. The BN approach, although able to consider many hundreds of genes simultaneously, can only be considered a qualitative approach to breaking down networks because the component proteins or genes are simply represented as either being present (state ¼ 1) or absent (state ¼ 0). However, BN approaches are currently the most accessible way to handle large networks and at the same time infer their quantitative behaviour through qualitative-based analyses [190] . With the increasing need to understand interactions in larger systems, it is likely that BN models will form an essential part of future works in the dynamic simulations of cancer networks. In contrast to traditional BNs, ODEs can dynamically represent protein concentration levels and therefore represents a more sophisticated, quantitative, approach. As discussed in previous sections, promising future directions will continue to build upon works, which integrate the ODE and BN approaches together [191] . Nevertheless, concentration and kinetic data are not always available for the proteins of interest. In terms of addressing the 'missing parameter' problem, a way forward is the use of parameter calculation and prediction from atomic structures of protein-protein complexes. Molecular simulations can be used for the calculation of kinetic parameters, particularly association rates [192] . However, dissociation rate calculation is somewhat less explored mainly due to their large time-scales that are hard to be estimated through simulations. A more accessible approach to circumvent the parameter limitation is through the prediction of such parameters from the structural analysis of macromolecular complexes at the atomic level, using Machine Learning [193] . Note that such parameter inference is not related to protein expression but is based entirely on the biophysical features of the protein monomer/complex in question.
Traditionally, atomic structure analysis and pathway analysis have been pursued separately. An exciting future direction in the dynamics of network simulations and particularly relevant to cancer is the impact of structural mutations on the network itself. A recent work in our own laboratory shows that the systemic impact of point mutations in proteins can be reasonably gauged by integrating protein stability change with the sensitivity of rate constants in ODE networks ( Figure 5 ). We believe that the combination of ODE networks with protein structural information will open a door to functional annotation of nsSNPs identified by genome wide association studies [194] .
Analysing the dynamics of cancer networks may also contribute to our understanding of cancer mechanisms. For example, the effect of multiple mutations accumulated in a tumour cells can be analysed by exploring their combinatorial impacts on the attractor landscape of a BN model: if a combination of specific mutations always converges to a steady state defined as cancerous, these mutations may be likely oncogenic. This approach may indirectly contribute to the differentiation between the 'driver' and 'passenger' mutations that are oncogenic and silent factors, respectively, in the progress of cancer development [195] . In particular, dynamic networks are also potentially useful for studying the signalling logic differences in 'healthy' and 'cancer' networks [196] , on top of their already-known application in biomarker discovery and cancer diagnosis [197] . Static network construction and analysis tools, particularly those developed in the context of constructing and interpreting the human interactome, can now be considered essential for understanding complex human diseases. However, as we all go in search for improved diagnosis classification, biomarker discovery, drug targets, and understanding of the drivers behind carcinogenesis, dynamic network analysis will play an increasing and significant role in each of these endeavours.
Key Points
The analysis of static PPI networks has been applied extensively in cancer diagnosis, biomarker discovery, drug development and oncogene identification. Along with the growth of publically available PPI databases, there is likely to be more diverse applications of network analysis in cancer studies. Analysing the dynamics of cancer networks can facilitate our understanding of cancers in the following aspects: developing better cancer diagnosis methods, improving the efficiency of biomarker discovery and increasing the accuracy of identifying the oncogenic (driver) genes. One future challenge in cancer network study is to develop integrative approaches that are able to analyse both qualitative and quantitative aspects of non-static networks (such as the integration of BN and ODE models discussed in this review). Another challenge is to develop advanced algorithms that are able to predict the value of parameters describing the kinetic rates of reactions included in a target cancer network. As a consequence of high-throughput genome-wide association studies, a large number of nsSNPs have been collected and are waiting to be analysed. Algorithms that are able to analyse the systemic impact of nsSNPs on cancer networksçpossibly through considering both protein structural information and cancer network dynamicsçare likely to contribute significantly to our understanding of cancer mechanisms in the future.
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